$8.70 $0.04 per serving
Product analysis
Melatonin 3 mg provides an economical, focused option for sleep timing and may help you fall asleep sooner.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality27
B6 is supplied in an identified form, while the melatonin form remains unclear. A firm quality judgment about both ingredients is therefore unavailable.
Ingredient Transparency81
Both ingredient amounts are disclosed, making serving comparisons easier. The melatonin form is not stated.
Value For Money78
The low serving cost supports favorable value for melatonin. There is not enough information to judge the value of the added B6.
Customer Satisfaction91
Customer feedback is favorable across thousands of reviews. The large review base supports a broad satisfaction picture.
Product Focus76
The main purpose is helping regulate sleep timing. Timing of use matters, and the sleep effect does not establish an additional immune or thinking benefit.
- Format
Lozenge - Container
- 180 Liquid(s)
- Per serving
- $0.04
- Also available
Melatonin 3 mg$4.65- Customer rating
- 4.8 · 5,362 ratings
Goals
Impact
Highest effect
Melatonin · 3 mg
Impact
Moderate effect
Vitamin B6 · 3 mg
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Vitamin B6 (Pyridoxine Hydrochloride) | 3 mg | |
Melatonin | 3 mg |
Melatonin · 3 mg OverallScore68
Each serving provides 3 mg of melatonin at a low cost per serving. It carries a GMP claim, but no independent finished-batch testing claim is available.
How this ingredient is rated
Active Ingredient Quality & Bioavailability20
It carries a GMP claim, but no independent finished-batch testing claim is available.
Third-Party Purity Verification
A GMP claim is present, but no independent finished-batch testing claim is available.
Dose, Safety & Label Transparency100
Each serving provides 3 mg of melatonin.
Physiological Dosing Alignment
The serving contains 3 mg of melatonin.
Value100
The cost per serving is low.
Price Per Serving Efficiency
The cost per serving is low.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease: A Systematic Review and Network Meta-Analysis.
- Melatonin for sleep and cognitive outcomes in older adults with cognitive impairment: a meta-analysis of randomised controlled trials.
- Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial.
- Early Oral Melatonin Supplementation Supports White Matter Maturation in Preterm Infants: Neuroprotective Insights of an Antioxidant Molecule.
- Efficacy and Safety of Melatonin in Migraine Prophylaxis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Vitamin B12, B6, or Folate and Cognitive Function in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis.
- Relationship between serum pyridoxal 5'-phosphate concentration and cognitive function in older Japanese.
- A randomized, controlled trial to evaluate the efficacy of pyridoxine and ascorbic acid on cognitive function and quality of life in post-menopausal women.
- Lower Plasma Vitamin B-6 is Associated with 2-Year Cognitive Decline in the Boston Puerto Rican Health Study.
- Are Dietary Supplements and Nutraceuticals Effective for Musculoskeletal Health and Cognitive Function? A Scoping Review.
- Exogenous melatonin boosts vaccine-induced immunity in individuals with high pre-existing influenza immunity.
- Evaluation of melatonin effectiveness in the adjuvant treatment of ulcerative colitis.
- Pineal-opioid system interactions in the control of immunoinflammatory responses.
- Influenza vaccine response is predicted by chronotype and differentially associated with pre- and post-vaccination sleep.
- Mechanisms and clinical evidence to support melatonin's use in severe COVID-19 patients to lower mortality.
- Meta-analysis: melatonin for the treatment of primary sleep disorders.
- Melatonin treatment for age-related insomnia.
- The Effectiveness of Melatonin for Sleep Disturbances in Parkinson' Disease: Systematic Review and Meta-Analysis.
- Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
- Effects of exogenous melatonin on sleep: a meta-analysis.